A superior vena cava (SVC) aneurysm is an extremely rare case of vascular malformation in the chest cavity. This is a report of a case of a 57-year-old woman with a saccular SVC aneurysm which was 8 cm wide. The chest computed tomography (CT) scan confirmed a giant 75 mm × 79 mm × 81 mm mass containing the contrast medium from SVC, constricting the right lung parenchyma, narrowing the right innominate vein, in contact with the anterolateral chest cavity wall, and adjoining the superior mediastinum.Under general anesthesia and employing the median sternotomy approach, using a cardiopulmonary bypass (CPB), the venous aneurysm was successfully resected. The postoperative period was uneventful. Radical surgical resection using a sternotomy and a CPB is recommended. and was entirely constricting the right upper lobe of the lung. After the mass was dissected from the right phrenic nerve and the surrounding tissue, we used a vascular clamp to exclude the neck of the aneurism. The mass was detached; the neck of the aneurysm was continuously sutured and strengthened with teflon felt patches (Figure 2).A histopathological examination was conducted and this confirmed that the mass which had been removed was a part of a venous blood vessel. A control CT scan and chest X-ray was done after surgery ( Figure 3). Because of an uneventful postoperative period, the patient was discharged on the 5th day after the procedure. DiscussionA vein aneurysm is an extremely rare phenomenon in medicine. In 1963, Abbot and Leight introduced a classification of aneurysms and divided them into four groups (congenital, acquired, pseudo-aneurysm, and arteriovenous aneurysm) (2). The fusiform aneurysm constitutes the vast majority. In our case we are presenting a saccular aneurysm, which has only been described in literature a few times. Such aneurysms are usually asymptomatic and are usually diagnosed accidentally in routine chest X-rays. Detailed diagnostics include a CT scan or magnetic resonance imaging (MRI). Aneurysms might be congenital, or caused by inflammation or by the degeneration of the vascular wall, but in most cases their cause is unknown (3). They might be solitary or they may coexist with cystic hygromas and angiomas. In asymptomatic patients where the diameter of the aneurysm is less than 40 mm, we might proceed conservatively, using anti-plaque therapy and periodic scans (4). Aneurysms which are larger, growing, symptomatic or containing thrombus require radical surgical treatment (3,5,6). Part of the thrombus forming the sack of the aneurysm can break away and cause pulmonary embolism or lung infarct which may lead to the patient's death (7,8). Particular caution is required in this circumstances. Thanks to CPB, our patient was protected from pulmonary embolism and lung infarct. The use of CPB should be considered not only when the thrombus formation is detected, but also in the case of calcification in the wall of the aneurysm (5). In our opinion, the type of surgical approach presented here gives better insight ...

The use of extracorporeal membrane oxygenation (ECMO) in patients with respiratory failure in the course of COVID-19 indicates its limited efficacy and high mortality rates. It seems that one of the conditions for the success of veno-venous ECMO (VV ECMO) in obese patients with COVID-19 is the correct qualification and rapid implementation of this method. We present two cases of obese patients with acute respiratory distress syndrome (ARDS) as a result of SARS-CoV-2 infection with the successful use of ECMO. Two 41-year-old obese patients (Case 1: BMI 31.5 kg/m2 and Case 2: 44.5 kg/m2), with pneumonia and severe respiratory failure in the course of COVID-19, underwent ECMO therapy. The Extracorporeal Life Support Organization (ELSO) guidelines were used to qualify the patients. Due to the persistence of PaO2/FiO2 rate <80 for 6 h, a decision was made to implement VV ECMO. Both patients were discharged from the intensive care unit (Case 1: on day 35; Case 2: on day 22). Rapid implementation of VV ECMO in middle-aged, obese patients with ARDS in the course of COVID-19 showed a positive outcome.

No abstract

Late onset cardiac tamponade is a rare and particularly challenging (both from diagnostic and management perspectives) complication of intracardiac lead implantation. We present a case of a late tamponade leading to cardiogenic shock, which occurred 1,164 days after implantable cardioverter-defibrillator (ICD) implantation. Open repair revealed unusual and, to our knowledge, not yet reported mechanism of the disease. A pressure sore caused by an ICD lead was found in the parietal layer of pericardium with no visible damage to the visceral layer. Conservative management in the described clinical scenario could be fatal, thus awareness of this pathomechanism of tamponade is critical.